cannabis sativa/抗炎症薬

BACKGROUND OF THE INVENTION 1. Field of Invention This application relates to anti-inflammatory agents, and in particular to the use of cannabinoids for the treatment of inflammatory diseases such as rheumatoid arthritis, multiple sclerosis and Crohn's Disease, and to medicinal preparations

FIELD OF THE INVENTION The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of

FIELD OF THE INVENTION The present invention, in some embodiments thereof, relates to fixed dose combination (FDC) compositions, more particularly, but not exclusively, to compositions comprising at least one cannabinoid as a plant isolate or synthetic, in essentially pure form or as a component of

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates generally to topical analgesic and anti-inflammation agents and more particularly to the use of a rapid-onset cannabinoid delivery topical liniment for the relief of pain and reduction in inflammation associated with such

FIELD OF THE INVENTION The present invention relates to non-psychotropic cannabinoids that are specific agonists of the peripheral cannabinoid receptor CB2. More particularly, the invention relates to pharmaceutical compositions comprising 4-phenyl pinene derivatives which are specific CB2 agonists

FIELD OF THE INVENTION The present invention relates to non-psychotropic cannabinoids that are specific agonists of the peripheral cannabinoid receptor CB2. More particularly, the invention relates to pharmaceutical compositions comprising 4-phenyl pinene derivatives which are specific CB2 agonists

FIELD OF THE INVENTION The present invention relates to non-psychotropic cannabinoids that are specific agonists of the peripheral cannabinoid receptor CB2. More particularly, the invention relates to pharmaceutical compositions comprising 4-phenyl pinene derivatives which are specific CB2 agonists

BACKGROUND OF THE INVENTION This invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory activity and are useful in

BACKGROUND OF THE INVENTION This invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory activity and are useful in

BACKGROUND OF THE INVENTION This invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory activity and are useful in

BACKGROUND The present invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory activity and are useful in treating

BACKGROUND The present invention relates to compounds useful as cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention can exhibit anti-inflammatory and immunomodulatory activity and are useful in

BACKGROUND OF THE INVENTION Field of the Invention The present invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory

BACKGROUND The present invention relates to cannabinoid receptor ligands and, more particularly, to compounds that bind to cannabinoid (CB.sub.2) receptors. Compounds according to the present invention generally exhibit anti-inflammatory and immunomodulatory activity and are useful in treating

BACKGROUND OF THE INVENTION This invention relates to certain novel octahydro-3-alkoxy-9-alkyl-phenanthridines and derivatives thereof and pharmaceutically acceptable acid addition salts thereof useful as antiinflammatory, analgesics, immunosuppressive, antiemetic and intraocular pressure reducing